Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)
Conditions: Cardiotoxicity; Neoplasms; Chemotherapy Effect; Heart Failure Interventions: Drug: Spironolactone; Drug: Placebo Sponsor: University of Sao Paulo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
Conditions: Alcohol Use Disorder; Hiv Intervention: Drug: Spironolactone Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)
Conditions: Cardiotoxicity; Neoplasms; Chemotherapy Effect; Heart Failure Interventions: Drug: Spironolactone; Drug: Placebo Sponsor: University of Sao Paulo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
Conditions: Alcohol Use Disorder; Hiv Intervention: Drug: Spironolactone Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)
Conditions: Cardiotoxicity; Neoplasms; Chemotherapy Effect; Heart Failure Interventions: Drug: Spironolactone; Drug: Placebo Sponsor: University of Sao Paulo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
Conditions: Alcohol Use Disorder; Hiv Intervention: Drug: Spironolactone Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)
Conditions: Cardiotoxicity; Neoplasms; Chemotherapy Effect; Heart Failure Interventions: Drug: Spironolactone; Drug: Placebo Sponsor: University of Sao Paulo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
Conditions: Alcohol Use Disorder; Hiv Intervention: Drug: Spironolactone Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)
Conditions: Cardiotoxicity; Neoplasms; Chemotherapy Effect; Heart Failure Interventions: Drug: Spironolactone; Drug: Placebo Sponsor: University of Sao Paulo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
Conditions: Alcohol Use Disorder; Hiv Intervention: Drug: Spironolactone Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)
Conditions: Cardiotoxicity; Neoplasms; Chemotherapy Effect; Heart Failure Interventions: Drug: Spironolactone; Drug: Placebo Sponsor: University of Sao Paulo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
Conditions: Alcohol Use Disorder; Hiv Intervention: Drug: Spironolactone Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)
Conditions: Cardiotoxicity; Neoplasms; Chemotherapy Effect; Heart Failure Interventions: Drug: Spironolactone; Drug: Placebo Sponsor: University of Sao Paulo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
Conditions: Alcohol Use Disorder; Hiv Intervention: Drug: Spironolactone Sponsors: Yale University; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX)
Conditions: Cardiotoxicity; Neoplasms; Chemotherapy Effect; Heart Failure Interventions: Drug: Spironolactone; Drug: Placebo Sponsor: University of Sao Paulo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials
